Search research articles
Contact Us
Filters
Showing results (551-560 of 597) with videos related to
Page
of 60
Sort By:
Advanced Healthcare Materials
|
June 18, 2024
On the Influence of Fabrication Methods and Materials for mRNA-LNP Production: From Size and Morphology to Internal Structure and mRNA Delivery Performance In Vitro and In Vivo
Dongdong Bi, Christoph Wilhelmy, Dennis Unthan, et al.
Haematologica
|
November 3, 2022
B- and T-cell acute lymphoblastic leukemias evade chemotherapy at distinct sites in the bone marrow
Malwine J Barz, Lena Behrmann, Danaëlle Capron, et al.
Gut Microbes
|
November 21, 2023
Inhibition of intestinal FXR activity as a possible mechanism for the beneficial effects of a probiotic mix supplementation on lipid metabolism alterations and weight gain in mice fed a high fat diet
Alice Beau, Bérengère Benoit, Mélanie Le Barz, et al.
ACS Nano
|
April 16, 2024
Superparamagnetic Iron Oxide Nanoparticles Reprogram the Tumor Microenvironment and Reduce Lung Cancer Regrowth after Crizotinib Treatment
Natalie K Horvat, Sara Chocarro, Oriana Marques, et al.
The Lancet. Haematology
|
September 24, 2021
CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials
Allison Barz Leahy, Haley Newman, Yimei Li, et al.
EMBO Molecular Medicine
|
November 23, 2022
X-linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL
Michela Carlet, Karin Schmelz, Jenny Vergalli, et al.
Cancer
|
September 26, 2019
Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and research
Molly McFatrich, Jennifer Brondon, Nicole R Lucas, et al.
Blood
|
December 6, 2021
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy
Allison Barz Leahy, Kaitlin J Devine, Yimei Li, et al.
Nature Communications
|
December 10, 2025
RoCK and ROI: single-cell transcriptomics with multiplexed enrichment of selected transcripts and region-specific sequencing
Giulia Moro, Izaskun Mallona, Malwine J Barz, et al.
British Journal of Pharmacology
|
January 29, 2014
Elucidation of the molecular mechanism and the efficacy in vivo of a novel 1,4-benzoquinone that inhibits 5-lipoxygenase
A M Schaible, R Filosa, V Temml, et al.
Page
of 60
Search research articles
Search
Showing results (551-560 of 597) with videos related to
Sort By:
Page
of 60
Advanced Healthcare Materials
|
June 18, 2024
On the Influence of Fabrication Methods and Materials for mRNA-LNP Production: From Size and Morphology to Internal Structure and mRNA Delivery Performance In Vitro and In Vivo
Dongdong Bi, Christoph Wilhelmy, Dennis Unthan, et al.
Haematologica
|
November 3, 2022
B- and T-cell acute lymphoblastic leukemias evade chemotherapy at distinct sites in the bone marrow
Malwine J Barz, Lena Behrmann, Danaëlle Capron, et al.
Gut Microbes
|
November 21, 2023
Inhibition of intestinal FXR activity as a possible mechanism for the beneficial effects of a probiotic mix supplementation on lipid metabolism alterations and weight gain in mice fed a high fat diet
Alice Beau, Bérengère Benoit, Mélanie Le Barz, et al.
ACS Nano
|
April 16, 2024
Superparamagnetic Iron Oxide Nanoparticles Reprogram the Tumor Microenvironment and Reduce Lung Cancer Regrowth after Crizotinib Treatment
Natalie K Horvat, Sara Chocarro, Oriana Marques, et al.
The Lancet. Haematology
|
September 24, 2021
CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials
Allison Barz Leahy, Haley Newman, Yimei Li, et al.
EMBO Molecular Medicine
|
November 23, 2022
X-linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL
Michela Carlet, Karin Schmelz, Jenny Vergalli, et al.
Cancer
|
September 26, 2019
Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and research
Molly McFatrich, Jennifer Brondon, Nicole R Lucas, et al.
Blood
|
December 6, 2021
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy
Allison Barz Leahy, Kaitlin J Devine, Yimei Li, et al.
Nature Communications
|
December 10, 2025
RoCK and ROI: single-cell transcriptomics with multiplexed enrichment of selected transcripts and region-specific sequencing
Giulia Moro, Izaskun Mallona, Malwine J Barz, et al.
British Journal of Pharmacology
|
January 29, 2014
Elucidation of the molecular mechanism and the efficacy in vivo of a novel 1,4-benzoquinone that inhibits 5-lipoxygenase
A M Schaible, R Filosa, V Temml, et al.
Page
of 60